R&D Partner Content 8th Gene Therapy Development Summit With 14 new gene therapy approvals in the last 18 months, billion-dollar collaborations, and the development of treatments for more common conditions, the gene therapy field is rapidly gaining mome
R&D Partner Content 4th Cell Therapy Potency Assay Summit In the ever-evolving cell therapy landscape, the challenge of potency assay development remains critical.
R&D Partner Content 10th Innate Killer Summit With recent expansion into autoimmune pipelines, the year of the ‘bounce back’ now feels in reach for the NK space.
R&D Partner Content 9th Commercialising Continuous Processing Summit 2025 The pivotal shift in biopharma priorities is steering towards enhancing sustainability measures for drug development.
Oncology Partner Content 9th Liquid Biopsy for Precision Oncology Summit 9th Liquid Biopsy for Precision Oncology Summit | February 18-20, 2025 | San Diego, CA | FREE* to Attend for Biopharma
R&D Partner Content Returning... The 5th Operationalize Expanded Access Programs... Welcome to, or welcome back to, the 5th Operationalize: Expanded Access Programs Summit 2025!
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.